AspireAssist may have made news back in 2013, but the controversial weight loss procedure has only now been approved by the FDA. Why is it controversial? Well, it is essentially a device that will allow people with obesity to pump food out of their stomachs. In a way, it sounds like sanctioned bulimia, hence the controversy.
Of course, there's a reason why the FDA approved AspireAssist. It is meant for people with a body mass index (BMI) of 35 to 55 who have failed to lose weight with non-surgical therapies. That's a very specific group AspireAssist is targeting. Essentially, those approved for the procedure will have a tube surgically implanted in their stomach with a port valve to attach another device. This second device is what helps sucks the food out.
Key Themes Behind This Trend
- Obesity Solutions
- AspireAssist's FDA approval is a sign of growing need for innovative solutions to obesity.
- Medical Device Innovation
- AspireAssist's approval highlights the potential for medical device companies to disrupt the obesity treatment industry.
- Controversial Health Tech
- AspireAssist's unique approach to weight loss raises questions about the ethical implications of controversial health tech.
Where This Applies
- Medical Devices
- AspireAssist's FDA approval reveals an opportunity for medical device companies to address obesity treatment.
- Healthcare
- AspireAssist's approval underscores the need for more innovative and effective treatments for obesity within the healthcare industry.
- Weight Loss Programs
- AspireAssist presents a potential disruption to the weight loss program industry by offering a unique approach to treating obesity.
